20 results
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
and Sections 302 and 906 related to certifications.
2.39 Cybersecurity; Data Protection. Except as would not reasonably be expected, individually
8-K
EX-1.1
CRNX
Crinetics Pharmaceuticals Inc
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
.
(ccc) Cybersecurity; Data Protection. Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect: (i
8-K
EX-1.1
3cmpt gz210dp25mn8ga
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-1.1
2jt6mtw
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
8-K
EX-1.1
mk0 3ittpk4im5
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
EX-1.1
ipjbs sh89
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
S-3
EX-1.2
3uy1ky 962p9lrd20t25
13 Aug 19
Shelf registration
4:36pm
10-K
7sb86al
13 Mar 19
Annual report
4:06pm
424B4
v54xxsn4hzx3w
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
urq4v5
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-1.1
bsfd3wgfm9br2n8 ppj
9 Jul 18
IPO registration (amended)
6:10am
S-1
z7l7r39 6lefr70
22 Jun 18
IPO registration
4:07pm
DRS/A
3fh061 0b
11 Jun 18
Draft registration statement (amended)
12:00am
DRS
p8bxyvez
3 May 18
Draft registration statement
12:00am
- Prev
- 1
- Next